醛固酮与直接肾素浓度比值联合醛固酮在老年高血压人群原发性醛固酮增多症筛查中的应用
Aldosterone to direct renin concentration ratio combined with aldosterone concentration for screening primary aldosteronism in elderly hypertensive patients
-
摘要: 目的探索老年高血压人群中筛查原发性醛固酮增多症(PA)的醛固酮与直接肾素浓度比值(ARR)的最佳切点,评价ARR联合醛固酮水平在提高筛查特异度中的作用,以减少确诊试验带来的风险。方法入选2016年3月至2019年3月,中国医学科学院阜外医院高血压病区收治的年龄60~80岁、经卡托普利抑制试验或静脉盐水负荷试验确诊为PA的患者65例,同时收集年龄、性别匹配的确诊为原发性高血压(EH)的患者118例。采用化学发光法测定直接肾素浓度、醛固酮浓度。根据ARR绘制受试者工作特征(ROC)曲线,取得最佳筛查切点。比较单用ARR与ARR联合醛固酮的ROC曲线下面积(AUC)。结果 ARR的AUC为0.859(95%CI 0.807~0.911)。ARR切点定在4.4 (ng/dL)/(mU/L)时,约登指数最高,此时诊断PA的敏感度为80.0%,特异度为78.8%。ARR≥4.4 (ng/dL)/(mU/L)联合醛固酮≥15 ng/dL时敏感度为72.3%,特异度为96.6%。联合ARR与醛固酮用于初筛PA时,AUC为0.911(95%CI 0.867~0.954),较单用ARR显著改善(P=0.038)。结论 ARR≥4.4 (ng/dL)/(mU/L)可考虑作为老年PA的初筛切点,联合醛固酮可改善筛查特异性。Abstract: Objective To explore the optimal cut-off point of aldosterone to renin concentration ratio(ARR) for screening primary aldosteronism(PA) in elderly hypertensive patients, and to evaluate effect of ARR combined with aldosterone in improving the screening specificity to reduce risk of confirmatory tests. Methods From March 2016 to March 2019, 65 patients aged 60-80 years old and diagnosed with PA by captopril challenge test or intravenous saline load test at the department of hypertension of Fuwai Hospital were enrolled. In the meantime, 118 age and gender matched patients with essential hypertension(EH) were also enrolled. Plasma renin and aldosterone concentrations were measured by chemiluminescent immunoassay. The receiver operating curve(ROC) of ARR was calculated and used to obtain the best screening cut-off point. The areas under the ROC curve(AUC) of ARR alone and ARR combined with aldosterone were compared. Results The AUC of the ARR was 0.859(95% CI 0.807-0.911). Youden index was at the highest when the upright ARR cut-off point was set at 4.4(ng/dL)/(mU/L), of which the sensitivity was 80.0% and the specificity was 78.8%. ARR cut-off at 4.4(ng/dL)/(mU/L) plus aldosterone cut-off point at 15 ng/dL was reasonable, of which the sensitivity was 72.3%, the specificity was 96.6%. When combined ARR with aldosterone for screening PA, AUC was 0.911(95% CI 0.867-0.954), which was significantly improved compared with the ARR alone(P=0.038). Conclusions ARR≥4.4(ng/dL)/(mU/L) can be considered as the primary screening cut-off point for elderly patients with PA. Combining upright ARR with aldosterone can improve screening specificity.